Radiopharm Theranostics Ltd
RAD
Company Profile
Business description
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
Contact
62 Lygon Street
Level 3, Carlton South
MelbourneVIC3053
AUST: +61 398245254
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
Stocks News & Analysis
video
ASX dividend stocks for 2025
With dividend yields at 25-year lows, it's time to rethink ASX stocks for income according to James Gruber.
stocks
Did the market overreact to Westpac results?
Shares fell more than 6.50 percent after the bank reported results.
stocks
Investors overly negative on undervalued ASX share
Road to profitability is in sight as management continues to take the right steps.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,756.70 | 55.20 | -0.63% |
| CAC 40 | 8,206.56 | 17.43 | 0.21% |
| DAX 40 | 22,844.50 | 46.41 | 0.20% |
| Dow JONES (US) | 44,474.82 | 71.26 | -0.16% |
| FTSE 100 | 8,766.73 | 1.28 | -0.01% |
| HKSE | 22,976.81 | 360.58 | 1.59% |
| NASDAQ | 20,006.63 | 20.15 | -0.10% |
| Nikkei 225 | 39,270.40 | 96.15 | 0.25% |
| NZX 50 Index | 13,051.12 | 17.81 | -0.14% |
| S&P 500 | 6,118.27 | 3.64 | 0.06% |
| S&P/ASX 200 | 8,481.00 | 56.10 | -0.66% |
| SSE Composite Index | 3,324.49 | 31.34 | -0.93% |